The displayed stock price includes nighttime trading information and is modestly lower than the previous day's close. A summary of the earnings release indicates that revenue reached a record high in the first quarter of the fiscal year ending March 2027 and that the company returned to profitability.
The stock price details show Shin Nippon Biomedical Laboratories, Ltd.'s price movements today: the previous close was ¥1,349, the opening price was ¥1,356, the high was ¥1,362 and the low was ¥1,344, with trading volume of 138,500 shares. No trading price is displayed for nighttime PTS trading, and the figure relative to the TSE closing price remains unreported. The next earnings announcement date is shown as undecided in the earnings information section.
According to the earnings release summary, revenue in the first quarter of the fiscal year ending March 2027 rose 21.5% year on year to ¥7.9 billion, a record high, helped by the recognition of a major CRO project that had been shifted between periods. Operating profit was ¥500 million, representing a return to profitability from the loss recorded in the same period of the previous year. Profit attributable to owners of the parent for the quarter rose 308.6% year on year to ¥1.1 billion.
The financial indicators show market capitalization of ¥56,120 million, 41,632,400 shares outstanding, a dividend yield of 3.71% and a dividend per share of ¥50 (forecast for the fiscal year ending March 2027). The minimum purchase amount is ¥134,800, PER is 16.03x, PBR is 1.34x, ROE is 10.98% and the equity ratio is 41.0%.
IFIS JAPAN is cited as the source for future analyst forecasts, and users are cautioned that some target-price histories after stock splits may not reflect the necessary adjustments.